Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Clinical Investigation, MSc, Northwestern University
… → 2002
Medicine, MD, University of Regensburg
… → 1994
Fingerprint
Dive into the research topics where Jochen Hanns-Martin Lorch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 15 Active
-
Prot #TP-CA-006: TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head & Neck Squamous Cell Carcinoma (HNSCC)
Lorch, J.H.-M. (PD/PI)
11/14/24 → 11/14/27
Project: Research project
-
Prot #ALE.C04.01: A Phase I/II, Open-Label, Multi-Center Study of ALE.C04 (anti-Claudin-1Antibody) as a Single Agent and in Combination with Pembrolizumab (anti-PD-1 antibody) in Adult Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cel
Lorch, J.H.-M. (PD/PI)
Ergomed Clinical Research Inc., Alentis Therapeutics AG
7/19/24 → 7/19/27
Project: Research project
-
Prot #XL092-305: A Phase 2/3, Randomized, Double-blind, Controlled Study of Zanzalintinib (XL092) in Combination with Pembrolizumab vs Pembrolizumab in the First-line Treatment of Subjects with PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous
Lorch, J.H.-M. (PD/PI)
Quintiles, Inc., Exelixis Inc.
5/22/24 → 5/22/27
Project: Research project
-
Prot #TAK-676-1002: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastat
Lorch, J.H.-M. (PD/PI)
Pharmaceutical Research Associates, Inc., Takeda Development Center Americas, Inc.
5/21/24 → 5/21/27
Project: Research project
-
A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma
Sehgal, K., Serritella, A. V., Liu, M., ONeill, A., Nangia, C., Pappa, T., Demeure, M. J., Worden, F. P., Haddad, R. I. & Lorch, J., May 1 2025, In: Journal of clinical endocrinology and metabolism. 110, 5, p. 1315-1323 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Are all programmed cell death protein 1 inhibitors the same?
Lorch, J. H., Stein, S. & Edelman, M. J., 2025, In: Frontiers in Oncology. 15, 1535030.Research output: Contribution to journal › Review article › peer-review
-
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer
Gennaro, N., Soliman, M., Borhani, A. A., Kelahan, L., Savas, H., Avery, R. J., Subedi, K., Trabzonlu, T. A., Krumpelman, C., Yaghmai, V., Chae, Y. K., Lorch, J., Mahalingam, D., Mulcahy, M., Benson III, A. B., Bagci, U. & Velichko, Y. S., Mar 2025, In: Tomography. 11, 3, 20.Research output: Contribution to journal › Article › peer-review
Open Access -
Survivorship therapy needs after radiotherapy for head and neck cancer: surveying opportunities for growth (STRONG)
Larson, A., Anna, Y., Sun, Z., Kingsbury, J., Stepan, K. O., Akthar, A., Lorch, J., Mittal, B. B., Yadav, P., Mierzwa, M. L., Mady, L. J. & Gharzai, L. A., May 2025, In: Supportive Care in Cancer. 33, 5, 403.Research output: Contribution to journal › Article › peer-review
-
DNA Anchoring Strength Directly Correlates with Spherical Nucleic Acid-Based HPV E7 Cancer Vaccine Potency
Hwang, J., Dittmar, J. W., Kang, J., Ocampo, T., Evangelopoulos, M., Han, Z., Kudruk, S., Lorch, J. & Mirkin, C. A., Jun 26 2024, In: Nano letters. 24, 25, p. 7629-7636 8 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations